| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Antigenic Specificity | PD-1 |
|---|
| Clone | monoclonal |
|---|
| Host Species | Human |
|---|
| Reactive Species | human |
|---|
| Isotype | IgG4 |
|---|
| Format | affinity purified |
|---|
| Size | 100 μg |
|---|
| Concentration | n/a |
|---|
| Applications | Neutralization, ELISA |
|---|
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
|---|
| Description | Monoclonal human IgG1 antibody against human PD-1. Nivolumab, trade name Opdivo, is a medication used to treat cancer. It is used as a first line treatment for inoperable or metastatic melanoma in combination with ipilimumab if the cancer does not have a mutation in BRAF, as a second-line treatment following treatment with ipilimumab and if the cancer has a mutation in BRAF, with a BRAF inhibitor, as a second-line treatment for squamous non-small cell lung cancer, and as a second-line treatment for renal cell carcinoma. |
|---|
| Immunogen | Human programmed cell death 1 receptor (PD1) |
|---|
| Other Names | Opdivo, PD-1 |
|---|
| Gene, Accession # | Gene ID: 18566, Accession: Q02242 |
|---|
| Catalog # | A1307-100 |
|---|
| Price | |
|---|
| Order / More Info | PD-1 Antibody from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|